CDK4/6 inhibition confers protection of normal gut epithelia against gemcitabine and the active metabolite of irinotecan

Taylor and Francis Group, Cell Cycle, 13(22), p. 1563-1582, 2023

Journal article published in 2023 by Joshua Blume

Distributing this paper is prohibited by the publisher

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by